Table 4.
Complications in the hospitalized Patients with the Novel Coronavirus (COVID-19) Infection.
| Complications | N (%) |
|---|---|
| All complications | 194 (39.0) |
| Neurological syndromes | 118 (23.7) |
| A) Encephalopathy | 94 (18.9) |
| B) Stroke | 16 (3.2) |
| Large artery stroke | 9 (1.8) |
| Small artery stroke | 2 (0.4) |
| Unclassified | 3 (0.6) |
| Transient Ischemic Attack (TIA) | 2 (0.4) |
| C) Meningitis | 2 (0.4) |
| D) Encephalitis | 1 (0.2) |
| E) Central nervous system vasculitis | 0 (0) |
| F) Myelitis/myelopathy | 0 (0) |
| G) ADEM | 0 (0) |
| H) GBS | 0 (0) |
| Myopathy | 4 (0.8) |
| Seizures | 12 (2.4) |
| Brain herniation | 5 (1.0) |
| Other unclassified neurological complications | 5 (1.0) |
| Acute kidney injury | 95 (19.1) |
| Sepsis/septic shock | 78 (15.7) |
| Pulmonary embolism | 21 (4.2) |
| Hepatic injury | 16 (3.2) |
| Cytokine storm | 12 (2.4) |
| Myocardial Infarction | 11 (2.2) |
| Pneumothorax or emphysema | 9 (1.8) |
| Thrombosis | 8 (1.6) |
| Pleural effusion | 2 (0.4) |
| Myopericarditis | 1 (0.2) |